Trial intelligence / Profile preview

Lorazepam for Anxiety and Postoperative Pain Reduction in Outpatient Third Molar Surgery (Split Mouth)

TCTR20231109001Phase 4Unknown

Sponsor
Ministry of Higher Education, Science, Research and Innovation
Start
Mar 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of lorazepam in anxiety disorder, postoperative pain, sponsored by Ministry of Higher Education, Science, Research and Innovation. Status: unknown.

02

Drugs

lorazepam
03

Conditions

anxiety disorderpostoperative pain

Beyond the preview

Go deeper on TCTR20231109001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20231109001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call